{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T04:13:17Z","timestamp":1792123997436,"version":"4.4.0"},"reference-count":132,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T00:00:00Z","timestamp":1714348800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T00:00:00Z","timestamp":1714348800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s11030-024-10862-4","type":"journal-article","created":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T11:03:29Z","timestamp":1714388609000},"page":"711-737","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Quinolone scaffolds as potential drug candidates against infectious microbes: a review"],"prefix":"10.1007","volume":"29","author":[{"given":"Vishal","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rina","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh Kumar","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diksha","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahbaz","family":"Aman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. U.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,29]]},"reference":[{"key":"10862_CR1","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/5584_2019_428","volume-title":"Advances in microbiology infectious diseases and public health","author":"L Senerovic","year":"2019","unstructured":"Senerovic L, Opsenica D, Moric I, Aleksic I, Spasic M, Vasiljevic B (2019) Quinolines and quinolones as antibacterial, antifungal, anti-virulence, antiviral and anti-parasitic Agents. In: Donelli G (ed) Advances in microbiology infectious diseases and public health, vol 14. Springer International Publishing, Cham, pp 37\u201369. https:\/\/doi.org\/10.1007\/5584_2019_428"},{"key":"10862_CR2","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.2174\/1568026622666220317162132","volume":"22","author":"W Zang","year":"2022","unstructured":"Zang W, Li D, Gao L, Gao S, Hao P, Bian B (2022) The antibacterial potential of ciprofloxacin hybrids against Staphylococcus aureus. Curr Top Med Chem 22:1020\u20131034. https:\/\/doi.org\/10.2174\/1568026622666220317162132","journal-title":"Curr Top Med Chem"},{"key":"10862_CR3","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1002\/phar.1636","volume":"35","author":"KS Kaye","year":"2015","unstructured":"Kaye KS, Pogue JM (2015) Infections caused by resistant gram-negative bacteria: epidemiology and management. Pharmacotherapy 35:949\u2013962. https:\/\/doi.org\/10.1002\/phar.1636","journal-title":"Pharmacotherapy"},{"key":"10862_CR4","doi-asserted-by":"publisher","first-page":"529","DOI":"10.4155\/fmc-2021-0009","volume":"13","author":"S Cascioferro","year":"2021","unstructured":"Cascioferro S, Parrino B, Carbone D, Pecoraro C, Diana P (2021) Novel strategies in the war against antibiotic resistance. Future Med Chem 13:529\u2013531. https:\/\/doi.org\/10.4155\/fmc-2021-0009","journal-title":"Future Med Chem"},{"key":"10862_CR5","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.1403","volume":"9","author":"SB Zaman","year":"2017","unstructured":"Zaman SB, Hussain MA, Nye R, Mehta V, Mamun KT, Hossain N (2017) A review on antibiotic resistance: alarm bells are ringing. Cureus 9:e1403. https:\/\/doi.org\/10.7759\/cureus.1403","journal-title":"Cureus"},{"key":"10862_CR6","unstructured":"https:\/\/www.who.int\/publications\/m\/item\/weekly-epidemiological-update-on-covid-19---22-march-2022."},{"key":"10862_CR7","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.jiph.2016.08.007","volume":"10","author":"M Frieri","year":"2017","unstructured":"Frieri M, Kumar K, Boutin A (2017) Antibiotic resistance. J Infect Public Health 10:369\u2013378. https:\/\/doi.org\/10.1016\/j.jiph.2016.08.007","journal-title":"J Infect Public Health"},{"key":"10862_CR8","doi-asserted-by":"publisher","first-page":"134","DOI":"10.3389\/fmicb.2010.00134","volume":"1","author":"RI Aminov","year":"2010","unstructured":"Aminov RI (2010) A brief history of the antibiotic era: lessons learned and challenges for the future. Front microbiol 1:134. https:\/\/doi.org\/10.3389\/fmicb.2010.00134","journal-title":"Front microbiol"},{"key":"10862_CR9","doi-asserted-by":"publisher","first-page":"859","DOI":"10.2174\/1573406418666220214085856","volume":"18","author":"M Saini","year":"2022","unstructured":"Saini M, Das R, Mehta DK, Chauhan S (2022) Styrylquinolines derivatives: SAR study and synthetic approaches. Med Chem 18:859\u2013870. https:\/\/doi.org\/10.2174\/1573406418666220214085856","journal-title":"Med Chem"},{"key":"10862_CR10","doi-asserted-by":"publisher","first-page":"69","DOI":"10.2174\/1389557521666210112142136","volume":"22","author":"V Sharma","year":"2022","unstructured":"Sharma V, Das R, Mehta DK (2022) Exploring quinolone scaffold: unravelling the chemistry of anticancer drug design. Mini-Rev Med Chem 22:69\u201388. https:\/\/doi.org\/10.2174\/1389557521666210112142136","journal-title":"Mini-Rev Med Chem"},{"key":"10862_CR11","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.2174\/1389557521666210225115055","volume":"21","author":"R Das","year":"2021","unstructured":"Das R, Mehta DK, Dhanawat M (2021) An elite scaffold and a wonder pharmacophore in drug discovery: styrylquinoline. Mini-Rev Med Chem 21:1849\u20131864. https:\/\/doi.org\/10.2174\/1389557521666210225115055","journal-title":"Mini-Rev Med Chem"},{"key":"10862_CR12","doi-asserted-by":"publisher","first-page":"E3463","DOI":"10.1073\/pnas.1717295115","volume":"115","author":"EY Klein","year":"2018","unstructured":"Klein EY, Van Boeckel TP, Martinez EM, Pant S, Gandra S, Levin SA, Goossens H, Laxminarayan R (2018) Global increase and geographic convergence in antibiotic consumption between 2000 and 2015. Proc Natl Acad Sci 115:E3463\u2013E3470. https:\/\/doi.org\/10.1073\/pnas.1717295115","journal-title":"Proc Natl Acad Sci"},{"key":"10862_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2022.116674","volume":"59","author":"V Sharma","year":"2022","unstructured":"Sharma V, Das R, Mehta DK, Gupta S, Venugopala KN, Mailavaram R, Deb PK (2022) Recent insight into the biological activities and SAR of quinolone derivatives as multifunctional scaffold. Bioorg Med Chem 59:116674. https:\/\/doi.org\/10.1016\/j.bmc.2022.116674","journal-title":"Bioorg Med Chem"},{"key":"10862_CR14","doi-asserted-by":"publisher","first-page":"128","DOI":"10.51847\/FE1iOIPTwD","volume":"11","author":"ZA Damanhouri","year":"2021","unstructured":"Damanhouri ZA, Alkreathy HM, Ali AS, Karim S (2021) The potential role of Fluoroquinolones in the management of Covid-19 a rapid review. J Adv Pharm Educ Res 11:128\u2013134. https:\/\/doi.org\/10.51847\/FE1iOIPTwD","journal-title":"J Adv Pharm Educ Res"},{"key":"10862_CR15","first-page":"396","volume":"25","author":"S Khatria","year":"2021","unstructured":"Khatria S, Kumara M, Pratibha RK (2021) A review of antifungal activities of various flouroquinolone and its metal complexes. Ann RSCB 25:396\u2013405","journal-title":"Ann RSCB"},{"key":"10862_CR16","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1007\/s00706-021-02806-7","volume":"152","author":"S Joshi","year":"2021","unstructured":"Joshi S, Yadav D, Yadav R (2021) Fluoroquinolones: a review on anti-tubercular activity. Monatshefte fur Chemie-Chem Monthly 152:881\u2013894. https:\/\/doi.org\/10.1007\/s00706-021-02806-7","journal-title":"Monatshefte fur Chemie-Chem Monthly"},{"key":"10862_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2021.113207","volume":"213","author":"PS Dube","year":"2021","unstructured":"Dube PS, Legoabe LJ, Jordaan A, Jesumoroti OJ, Tshiwawa T, Warner DF, Beteck RM (2021) Easily accessed nitroquinolones exhibiting potent and selective anti-tubercular activity. Eur J Med Chem 213:113207. https:\/\/doi.org\/10.1016\/j.ejmech.2021.113207","journal-title":"Eur J Med Chem"},{"key":"10862_CR18","doi-asserted-by":"publisher","first-page":"10","DOI":"10.9734\/ijbcrr\/2020\/v29i830208","volume":"29","author":"TA Balogun","year":"2020","unstructured":"Balogun TA, Omoboyowa DA, Saibu OA (2020) In silico anti-malaria activity of quinolone compounds against Plasmodium falciparum dihydrofolate reductase (pfDHFR). Int J Biochem Res Rev 29:10\u201317. https:\/\/doi.org\/10.9734\/ijbcrr\/2020\/v29i830208","journal-title":"Int J Biochem Res Rev"},{"key":"10862_CR19","doi-asserted-by":"publisher","DOI":"10.5772\/intechopen.97084","volume-title":"A comprehensive review of 4 (1H)-quinolones and 4 (1H)-pyridones for the development of an effective antimalarial, plasmodium species and drug resistance","author":"AH Asakawa","year":"2021","unstructured":"Asakawa AH, Manetsch R (2021) A comprehensive review of 4 (1H)-quinolones and 4 (1H)-pyridones for the development of an effective antimalarial, plasmodium species and drug resistance. Intechopen, London. https:\/\/doi.org\/10.5772\/intechopen.97084"},{"key":"10862_CR20","doi-asserted-by":"publisher","first-page":"69","DOI":"10.2174\/1389557521666210112142136","volume":"22","author":"V Sharma","year":"2022","unstructured":"Sharma V, Das R, Mehta DK, Sharma D, Sahu RK (2022) Exploring quinolone scaffold: unravelling the chemistry of anticancer drug design. Mini-Rev Med Chem 22:69\u201388. https:\/\/doi.org\/10.2174\/1389557521666210112142136","journal-title":"Mini-Rev Med Chem"},{"key":"10862_CR21","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/s41429-020-0278-5","volume":"73","author":"K Tabara","year":"2020","unstructured":"Tabara K, Tamura R, Nakamura A, Mori S, Kitano T, Fujikawa K, Okamoto K, Kanayama S, Uratsuji H, Ikeda F, Matsumoto T (2020) Anti-inflammatory effects of ozenoxacin, a topical quinolone antimicrobial agent. J Antibiot 73:247\u2013254. https:\/\/doi.org\/10.1038\/s41429-020-0278-5","journal-title":"J Antibiot"},{"key":"10862_CR22","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1021\/acs.oprd.1c00099","volume":"25","author":"S Pou","year":"2021","unstructured":"Pou S, Dodean RA, Frueh L, Liebman KM, Gallagher RT, Jin H, Winter RW (2021) New scalable synthetic routes to ELQ-300, ELQ-316, and other antiparasitic quinolones. Org Process Res Dev 25:1841\u20131852. https:\/\/doi.org\/10.1021\/acs.oprd.1c00099","journal-title":"Org Process Res Dev"},{"key":"10862_CR23","doi-asserted-by":"publisher","DOI":"10.5772\/intechopen.92577","volume-title":"Antimicrobial resistance - A one health perspective","author":"SG Solano-Galvez","year":"2020","unstructured":"Solano-Galvez SG, Valencia-Segrove MF, Prado MJO, Boucieguez ABL, Alvarez-Hernandez DA, Vazquez-Lopez R (2020) Mechanisms of resistance to quinolones. In: Mare\u0219 M, Lim SHE, Lai K, Cristina R (eds) Antimicrobial resistance - A one health perspective. IntechOpen, London. https:\/\/doi.org\/10.5772\/intechopen.92577"},{"key":"10862_CR24","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/bs.aihch.2020.08.001","volume":"135","author":"AA Aly","year":"2020","unstructured":"Aly AA, Ramadan M, Abuo-Rahma GEDA, Elshaier YAMM, Elbastawesy MA, Brown AB, Brase S (2020) Quinolones as prospective drugs: their syntheses and biological applications. Adv Heterocycl Chem 135:147\u2013196. https:\/\/doi.org\/10.1016\/bs.aihch.2020.08.001","journal-title":"Adv Heterocycl Chem"},{"key":"10862_CR25","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1039\/c9md00120d","volume":"10","author":"TDM Pham","year":"2019","unstructured":"Pham TDM, Ziora Z, Blaskovich M (2019) Quinolone Antibiotics. Med Chem Comm 10:1719\u20131739. https:\/\/doi.org\/10.1039\/c9md00120d","journal-title":"Med Chem Comm"},{"key":"10862_CR26","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1093\/jac\/dkg207","volume":"51","author":"PM Hawkey","year":"2003","unstructured":"Hawkey PM (2003) Mechanisms of quinolone action and microbial response. J Antimicrob Chemother 51:29\u201335. https:\/\/doi.org\/10.1093\/jac\/dkg207","journal-title":"J Antimicrob Chemother"},{"key":"10862_CR27","first-page":"263","volume-title":"Recent developments in inhibitors of bacterial type IIA topoisomerases. Antibiotics: targets, mechanisms and resistance","author":"PF Chan","year":"2013","unstructured":"Chan PF, Huang J, Bax BD, Gwynn MN (2013) Recent developments in inhibitors of bacterial type IIA topoisomerases. Antibiotics: targets, mechanisms and resistance. Wiley, Hoboken, pp 263\u2013297"},{"key":"10862_CR28","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1021\/bi5000564","volume":"53","author":"KJ Aldred","year":"2014","unstructured":"Aldred KJ, Kerns RJ, Osheroff N (2014) Mechanism of quinolone action and resistance. Biochem 53:1565\u20131574. https:\/\/doi.org\/10.1021\/bi5000564","journal-title":"Biochem"},{"key":"10862_CR29","doi-asserted-by":"publisher","first-page":"3260","DOI":"10.1128\/aac.47.10.3260-3269.2003","volume":"47","author":"AM Nilius","year":"2003","unstructured":"Nilius AM, Shen LL, Hensey-Rudloff D, Almer LS, Beyer JM, Balli DJ, Cai Y, Flamm RK (2003) In vitro antibacterial potency and spectrum of abt-492, a new fluoroquinolone. Antimicrob Agents Chemother 47:3260\u20133269. https:\/\/doi.org\/10.1128\/aac.47.10.3260-3269.2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10862_CR30","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1007\/s40265-017-0790-5","volume":"77","author":"A Markham","year":"2017","unstructured":"Markham A (2017) Delafloxacin: first global approval. Drugs 77:1481\u20131486. https:\/\/doi.org\/10.1007\/s40265-017-0790-5","journal-title":"Drugs"},{"key":"10862_CR31","doi-asserted-by":"publisher","first-page":"981","DOI":"10.2174\/156802609789630947","volume":"9","author":"K Drlica","year":"2009","unstructured":"Drlica K, Hiasa H, Kerns R, Malik M, Mustaev A, Zhao X (2009) Quinolones: action and resistance updated. Curr Top Med Chem 9:981\u2013998. https:\/\/doi.org\/10.2174\/156802609789630947","journal-title":"Curr Top Med Chem"},{"key":"10862_CR32","doi-asserted-by":"publisher","first-page":"10064","DOI":"10.1073\/pnas.1901730116","volume":"116","author":"Y Hong","year":"2019","unstructured":"Hong Y, Zeng J, Wang X, Drlica K, Zhao X (2019) Post-stress bacterial cell death mediated by reactive oxygen species. Proc Natl Acad Sci 116:10064\u201310071. https:\/\/doi.org\/10.1073\/pnas.1901730116","journal-title":"Proc Natl Acad Sci"},{"key":"10862_CR33","doi-asserted-by":"publisher","first-page":"5844","DOI":"10.3390\/ijms20235844","volume":"20","author":"Annunziato,","year":"2019","unstructured":"Annunziato, (2019) Strategies to overcome antimicrobial resistance (amr) making use of non-essential target inhibitors: a review. Int J Mol Sci 20:5844. https:\/\/doi.org\/10.3390\/ijms20235844","journal-title":"Int J Mol Sci"},{"key":"10862_CR34","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.tmaid.2010.12.002","volume":"9","author":"SC Arya","year":"2011","unstructured":"Arya SC, Agarwal N (2011) International travel with acquisition of multi-drug resistant gram negative bacteria containing the New Delhi metallo-beta-lactamase gene, bla (NDM-1). Travel Med Infect Dis 9:47\u201348. https:\/\/doi.org\/10.1016\/j.tmaid.2010.12.002","journal-title":"Travel Med Infect Dis"},{"key":"10862_CR35","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/S1473-3099(11)70059-7","volume":"11","author":"TR Walsh","year":"2011","unstructured":"Walsh TR, Weeks J, Livermore DM, Toleman MA (2011) Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study. Lancet Infect Dis 11:355\u2013362. https:\/\/doi.org\/10.1016\/S1473-3099(11)70059-7","journal-title":"Lancet Infect Dis"},{"key":"10862_CR36","doi-asserted-by":"publisher","first-page":"FSO290","DOI":"10.4155\/fsoa-2017-0109","volume":"4","author":"J Ali","year":"2018","unstructured":"Ali J, Rafiq QA, Ratcliffe E (2018) Antimicrobial resistance mechanisms and potential synthetic treatments. Fut Sci OA 4:FSO290. https:\/\/doi.org\/10.4155\/fsoa-2017-0109","journal-title":"Fut Sci OA"},{"key":"10862_CR37","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1186\/2047-783X-15-12-571","volume":"15","author":"MH Wilke","year":"2010","unstructured":"Wilke MH (2010) Multiresistant bacteria and current therapy\u2014the economical side of the story. Eur J Med Res 15:571\u2013576. https:\/\/doi.org\/10.1186\/2047-783X-15-12-571","journal-title":"Eur J Med Res"},{"key":"10862_CR38","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1002\/jhet.3514","volume":"56","author":"S Nirwan","year":"2019","unstructured":"Nirwan S, Chahal V, Kakkar R (2019) Thiazolidinones: synthesis, reactivity, and their biological applications. J Heterocycl Chem 56:1239\u20131253. https:\/\/doi.org\/10.1002\/jhet.3514","journal-title":"J Heterocycl Chem"},{"key":"10862_CR39","doi-asserted-by":"publisher","first-page":"S120","DOI":"10.1086\/428052","volume":"41","author":"GA Jacoby","year":"2005","unstructured":"Jacoby GA (2005) Mechanisms of resistance to quinolones. Clin Infect Dis 41:S120-126. https:\/\/doi.org\/10.1086\/428052","journal-title":"Clin Infect Dis"},{"key":"10862_CR40","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.3390\/pharmaceutics14081749","volume":"14","author":"IA Lungu","year":"2022","unstructured":"Lungu IA, Moldovan OL, Biri\u0219 V, Rusu A (2022) Fluoroquinolones hybrid molecules as promising antibacterial agents in the fight against antibacterial resistance. Pharmaceutics 14:1749. https:\/\/doi.org\/10.3390\/pharmaceutics14081749","journal-title":"Pharmaceutics"},{"key":"10862_CR41","doi-asserted-by":"publisher","unstructured":"Fair RJ, Tor Y (2014) Antibiotics and bacterial resistance in the 21st century. Perspectives in med chem 6:PMC-S14459. https:\/\/doi.org\/10.4137\/PMC.S14459.","DOI":"10.4137\/PMC.S14459"},{"key":"10862_CR42","doi-asserted-by":"publisher","first-page":"833","DOI":"10.3389\/fmicb.2016.00833","volume":"7","author":"AV Vargiu","year":"2016","unstructured":"Vargiu AV, Pos KM, Poole K, Nikaido H (2016) Bad bugs in the XXIst century: resistance mediated by multi-drug efflux pumps in Gram-negative bacteria. Front microbiol 7:833. https:\/\/doi.org\/10.3389\/fmicb.2016.00833","journal-title":"Front microbiol"},{"key":"10862_CR43","doi-asserted-by":"publisher","unstructured":"Admassie M (2018) Current review on molecular and phenotypic mechanism of bacterial resistance to antibiotic Sci J Clin Med 7:13. https:\/\/doi.org\/10.11648\/j.sjcm.20180702.11.","DOI":"10.11648\/j.sjcm.20180702.11"},{"key":"10862_CR44","doi-asserted-by":"publisher","first-page":"5286","DOI":"10.3390\/molecules20045286","volume":"20","author":"A Penesyan","year":"2015","unstructured":"Penesyan A, Gillings M, Paulsen IT (2015) Antibiotic discovery: combatting bacterial resistance in cells and in biofilm communities. Molecules 20:5286\u20135298. https:\/\/doi.org\/10.3390\/molecules20045286","journal-title":"Molecules"},{"key":"10862_CR45","doi-asserted-by":"publisher","first-page":"4447","DOI":"10.1128\/jb.01655-07","volume":"190","author":"L Zhang","year":"2008","unstructured":"Zhang L, Mah T (2008) Involvement of a novel efflux system in biofilm-specific resistance to antibiotics. J Bacteriol 190:4447\u20134452. https:\/\/doi.org\/10.1128\/jb.01655-07","journal-title":"J Bacteriol"},{"key":"10862_CR46","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.coph.2014.09.005","volume":"18","author":"C Beloin","year":"2014","unstructured":"Beloin C, Renard S, Ghigo JM, Lebeaux D (2014) Novel approaches to combat bacterial biofilms. Curr Opin Pharmacol 18:61\u201368. https:\/\/doi.org\/10.1016\/j.coph.2014.09.005","journal-title":"Curr Opin Pharmacol"},{"key":"10862_CR47","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.mib.2013.07.006","volume":"16","author":"P Sass","year":"2013","unstructured":"Sass P, Br\u00f6tz-Oesterhelt H (2013) Bacterial cell division as a target for new antibiotics. Curr Opin Microbiol 16:522\u2013530. https:\/\/doi.org\/10.1016\/j.mib.2013.07.006","journal-title":"Curr Opin Microbiol"},{"key":"10862_CR48","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1074\/jbc.M115.691725","volume":"291","author":"M Urfer","year":"2016","unstructured":"Urfer M, Bogdanovic J, Lo Monte F, Moehle K, Zerbe K, Omasits U, Ahrens CH, Pessi G, Eberl L (2016) A peptidomimetic antibiotic targets outer membrane proteins and disrupts selectively the outer membrane in Escherichia coli. J Biol Chem 291:1921\u20131932. https:\/\/doi.org\/10.1074\/jbc.M115.691725","journal-title":"J Biol Chem"},{"key":"10862_CR49","doi-asserted-by":"publisher","first-page":"889","DOI":"10.2147\/IJN.S40599","volume":"8","author":"VV Thekkae Padil","year":"2013","unstructured":"Thekkae Padil VV, Cern\u00edk M (2013) Green synthesis of copper oxide nanoparticles using gum karaya as a biotemplate and their antibacterial application. Int J Nanomedicine 8:889\u2013898. https:\/\/doi.org\/10.2147\/IJN.S40599","journal-title":"Int J Nanomedicine"},{"key":"10862_CR50","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1086\/599225","volume":"48","author":"JD Hartzell","year":"2009","unstructured":"Hartzell JD, Neff R, Ake J, Howard R, Olson S, Paolino K, Vishnepolsky M, Weintrob A, Wortmann G (2009) nephrotoxicity associated with intravenous colistin (colistimethate sodium) treatment at a tertiary care medical center. Clin Infect Dis 48:1724\u20131728. https:\/\/doi.org\/10.1086\/599225","journal-title":"Clin Infect Dis"},{"key":"10862_CR51","doi-asserted-by":"publisher","first-page":"288","DOI":"10.3390\/pathogens2020288","volume":"2","author":"D Lebeaux","year":"2013","unstructured":"Lebeaux D, Chauhan A, Rendueles O, Beloin C (2013) From in vitro to in vivo models of bacterial biofilm-related infections. Pathogens 2:288\u2013356. https:\/\/doi.org\/10.3390\/pathogens2020288","journal-title":"Pathogens"},{"key":"10862_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2016.00470","volume":"7","author":"G Cheng","year":"2016","unstructured":"Cheng G, Dai M, Ahmed S, Hao H, Wang X, Yuan Z (2016) Antimicrobial drugs in fighting against antimicrobial resistance. Front microbiol 7:181062. https:\/\/doi.org\/10.3389\/fmicb.2016.00470","journal-title":"Front microbiol"},{"key":"10862_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s11671-020-03418-6","volume":"15","author":"B Abebe","year":"2020","unstructured":"Abebe B, Zereffa EA, Tadesse A, Murthy HA (2020) A review on enhancing the antibacterial activity of ZnO: Mechanisms and microscopic investigation. Nanoscale Res Lett 15:1\u201319. https:\/\/doi.org\/10.1186\/s11671-020-03418-6","journal-title":"Nanoscale Res Lett"},{"key":"10862_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(05)70189-4","author":"IN Okeke","year":"2005","unstructured":"Okeke IN, Laxminarayan R, Bhutta ZA, Duse AG, Jenkins P, O\u2019Brien TF, Pablos-Mendez A, Klugman KP (2005) Antimicrobial resistance in developing countries. Part I: recent trends and current status. Lancet Infectious Dis. https:\/\/doi.org\/10.1016\/S1473-3099(05)70189-4","journal-title":"Lancet Infectious Dis"},{"key":"10862_CR55","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.ejmech.2017.09.050","volume":"141","author":"YQ Hu","year":"2017","unstructured":"Hu YQ, Zhang S, Xu Z, Lv ZS, Liu ML, Feng LS (2017) 4-Quinolone hybrids and their antibacterial activities. Eur J Med Chem 141:335\u2013345. https:\/\/doi.org\/10.1016\/j.ejmech.2017.09.050","journal-title":"Eur J Med Chem"},{"key":"10862_CR56","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/nyas.12830","volume":"1354","author":"DC Hooper","year":"2015","unstructured":"Hooper DC, Jacoby GA (2015) Mechanisms of drug resistance: quinolone resistance. Ann N Y Acad Sci 1354:12\u201331. https:\/\/doi.org\/10.1111\/nyas.12830","journal-title":"Ann N Y Acad Sci"},{"key":"10862_CR57","doi-asserted-by":"publisher","first-page":"5662","DOI":"10.3390\/molecules25235662","volume":"25","author":"NG Bush","year":"2020","unstructured":"Bush NG, Diez-Santos I, Abbott LR, Maxwell A (2020) Quinolones: mechanism, lethality and their contributions to antibiotic resistance. Molecules 25:5662. https:\/\/doi.org\/10.3390\/molecules25235662","journal-title":"Molecules"},{"key":"10862_CR58","first-page":"587","volume":"66","author":"PC Sharma","year":"2009","unstructured":"Sharma PC, Jain A, Jain S (2009) Fluoroquinolone antibacterials: a review on chemistry, microbiology and therapeutic prospects. Acta Pol Pharm 66:587\u2013604","journal-title":"Acta Pol Pharm"},{"key":"10862_CR59","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/j.1751-7915.2008.00063.x","volume":"2","author":"A Fabrega","year":"2009","unstructured":"Fabrega A, Madurga S, Giralt E, Vila J (2009) Mechanism of action of and resistance to quinolones. Microb Biotechnol 2:40\u201361. https:\/\/doi.org\/10.1111\/j.1751-7915.2008.00063.x","journal-title":"Microb Biotechnol"},{"key":"10862_CR60","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/978-1-4939-7459-7_3","volume-title":"DNA Topoisomerases: methods and protocols; methods in molecular biology","author":"H Hiasa","year":"2018","unstructured":"Hiasa H (2018) DNA topoisomerases as targets for antibacterial agents. In: Drolet M (ed) DNA Topoisomerases: methods and protocols; methods in molecular biology. Humana Press, New York, pp 47\u201362"},{"key":"10862_CR61","doi-asserted-by":"publisher","first-page":"11153","DOI":"10.3390\/molecules180911153","volume":"18","author":"V Uivarosi","year":"2013","unstructured":"Uivarosi V (2013) Metal complexes of quinolone antibiotics and their applications: an update. Mol Basel Switz 18:11153\u201311197. https:\/\/doi.org\/10.3390\/molecules180911153","journal-title":"Mol Basel Switz"},{"key":"10862_CR62","doi-asserted-by":"publisher","first-page":"12300","DOI":"10.1074\/jbc.M113.529164","volume":"289","author":"A Mustaev","year":"2014","unstructured":"Mustaev A, Malik M, Zhao X, Kurepina N, Luan G, Oppegard LM, Hiasa H, Marks KR, Kerns RJ, Berger JM, Drlica K (2014) Fluoroquinolone-gyrase-DNA complexes. J Biol Chem 289:12300\u201312312. https:\/\/doi.org\/10.1074\/jbc.M113.529164","journal-title":"J Biol Chem"},{"key":"10862_CR63","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1093\/molbev\/msz214","volume":"37","author":"RAD Castro","year":"2020","unstructured":"Castro RAD, Ross A, Kamwela L, Reinhard M, Loiseau C, Feldmann J, Borrell S, Trauner A, Gagneux S (2020) The genetic background modulates the evolution of fluoroquinolone-resistance in Mycobacterium tuberculosis. Mol Biol Evol 37:195\u2013207. https:\/\/doi.org\/10.1093\/molbev\/msz214","journal-title":"Mol Biol Evol"},{"key":"10862_CR64","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1055\/s-0030-1270782","volume":"77","author":"R Rodriguez-Guzman","year":"2011","unstructured":"Rodriguez-Guzman R, Fulks LCJ, Radwan MM, Burandt CL, Ross SA (2011) Chemical constituents, antimicrobial and antimalarial activities of Zanthoxylum monophyllum. Planta Med 77:1542\u20131544. https:\/\/doi.org\/10.1055\/s-0030-1270782","journal-title":"Planta Med"},{"key":"10862_CR65","doi-asserted-by":"publisher","first-page":"4488","DOI":"10.1021\/acs.jmedchem.5b01678","volume":"59","author":"SF Cui","year":"2016","unstructured":"Cui SF, Addla D, Zhou CH (2016) Novel 3-aminothiazolquinolones: design, synthesis, bioactive evaluation, SARs, and preliminary antibacterial mechanism. J Med Chem 59:4488\u20134510. https:\/\/doi.org\/10.1021\/acs.jmedchem.5b01678","journal-title":"J Med Chem"},{"key":"10862_CR66","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1016\/j.ejmech.2017.10.042","volume":"143","author":"HM Faidallah","year":"2018","unstructured":"Faidallah HM, Girgis AS, Tiwari AD, Honkanadavar HH, Thomas SJ, Samir A et al (2018) Synthesis, antibacterial properties and 2D-QSAR studies of quinolone-triazole conjugates. Eur J Med Chem 143:1524\u20131534. https:\/\/doi.org\/10.1016\/j.ejmech.2017.10.042","journal-title":"Eur J Med Chem"},{"key":"10862_CR67","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.ejmech.2016.08.031","volume":"124","author":"R Kant","year":"2016","unstructured":"Kant R, Singh V, Nath G, Awasthi SK, Agarwal A (2016) Design, synthesis and biological evaluation of ciprofloxacin tethered bis-1, 2, 3-triazole conjugates as potent antibacterial agents. Eur J Med Chem 124:218\u2013228. https:\/\/doi.org\/10.1016\/j.ejmech.2016.08.031","journal-title":"Eur J Med Chem"},{"key":"10862_CR68","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s40199-018-0226-0","volume":"26","author":"A Asadipour","year":"2018","unstructured":"Asadipour A, Moshafi MH, Khosravani L, Moghimi S, Amou E, Firoozpour L, Ilbeigi G, Beiki K, Soleimani E, Foroumadi A (2018) N-substituted piperazinyl sarafloxacin derivatives: synthesis and in vitro antibacterial evaluation. DARU J Pharm Sci 26:199\u2013207. https:\/\/doi.org\/10.1007\/s40199-018-0226-0","journal-title":"DARU J Pharm Sci"},{"key":"10862_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2020.112513","volume":"202","author":"AA Mohammed","year":"2020","unstructured":"Mohammed AA, Suaifan GA, Shehadeh MB, Okechukwu PN (2020) Design, synthesis and antimicrobial evaluation of novel glycosylated-fluoroquinolones derivatives. Eur J Med Chem 202:112513. https:\/\/doi.org\/10.1016\/j.ejmech.2020.112513","journal-title":"Eur J Med Chem"},{"key":"10862_CR70","doi-asserted-by":"publisher","DOI":"10.1002\/slct.202201366","volume":"7","author":"AK Soda","year":"2022","unstructured":"Soda AK, Kurva S, Singh K, Veeragoni D, Misra S, Murahari M, Madabhushi S (2022) Synthesis and pharmacological evaluation of hexafluoro functionalized quinolone derivatives as potential chemotherapeutic agents. ChemistrySelect 7:e202201366. https:\/\/doi.org\/10.1002\/slct.202201366","journal-title":"ChemistrySelect"},{"key":"10862_CR71","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3390\/sci4030030","volume":"4","author":"A Mahajan","year":"2022","unstructured":"Mahajan A, Singh H, Singh A, Agrawal DK, Arora A, Chundawat TS (2022) Trifluoromethylated quinolone-hydantoin hybrids: synthesis and antibacterial evaluation. Sci 4:30. https:\/\/doi.org\/10.3390\/sci4030030","journal-title":"Sci"},{"key":"10862_CR72","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1021\/acs.jnatprod.6b01085","volume":"80","author":"HA Raja","year":"2017","unstructured":"Raja HA, Miller AN, Pearce CJ, Oberlies NH (2017) Fungal identification using molecular tools: a primer for the natural products research community. J Nat Prod 80:756\u2013770. https:\/\/doi.org\/10.1021\/acs.jnatprod.6b01085","journal-title":"J Nat Prod"},{"key":"10862_CR73","doi-asserted-by":"publisher","first-page":"1800382","DOI":"10.1002\/ardp.201800382","volume":"352","author":"B Zhang","year":"2019","unstructured":"Zhang B (2019) Quinolone derivatives and their antifungal activities: an overview. Arch Pharm 352:1800382. https:\/\/doi.org\/10.1002\/ardp.201800382","journal-title":"Arch Pharm"},{"key":"10862_CR74","doi-asserted-by":"publisher","first-page":"5259","DOI":"10.1007\/s00253-021-11407-7","volume":"105","author":"Q Zhang","year":"2021","unstructured":"Zhang Q, Liu F, Zeng M, Mao Y, Song Z (2021) Drug repurposing strategies in the development of potential antifungal agents. Appl Microbiol Biotechnol 105:5259\u20135279. https:\/\/doi.org\/10.1007\/s00253-021-11407-7","journal-title":"Appl Microbiol Biotechnol"},{"key":"10862_CR75","first-page":"37","volume-title":"Quinolines and quinolones as antibacterial, antifungal, anti-virulence, antiviral and anti-parasitic agents. Infectious diseases and public health","author":"L Senerovic","year":"2020","unstructured":"Senerovic L, Opsenica D, Moric I, Aleksic I, Spasic M, Vasiljevic B (2020) Quinolines and quinolones as antibacterial, antifungal, anti-virulence, antiviral and anti-parasitic agents. Infectious diseases and public health. Springer, Cham, pp 37\u201369"},{"key":"10862_CR76","doi-asserted-by":"publisher","first-page":"2880","DOI":"10.3390\/molecules13112880","volume":"13","author":"Y Al-Hiari","year":"2008","unstructured":"Al-Hiari Y, Abu-Dahab R, El-Abadelah M (2008) Heterocycles [h]-Fused Onto 4-Oxoquinoline-3-Carboxylic Acid, Part VIII [1]. Convenient Synthesis and Antimicrobial Properties of Substituted Hexahydro[1,4]diazepino[2,3-h]quinoline-9-carboxylic acid and Its Tetrahydroquino[7,8-b]benzodiazepine Analog. Molecules 13:2880\u20132893. https:\/\/doi.org\/10.3390\/molecules13112880","journal-title":"Molecules"},{"key":"10862_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2021.130652","volume":"1241","author":"O Moussaoui","year":"2021","unstructured":"Moussaoui O, Byadi S, Eddine Hachim M, Sghyar R, Bahsis L, Moslova K, Aboulmouhajir A, Rodi YK, Podlipnik C, Hadrami EL, E, Chakroune S, (2021) Selective synthesis of novel quinolones-amino esters as potential antibacterial and antifungal agents: experimental, mechanistic study, docking and molecular dynamic simulations. J Mol Struct 1241:130652. https:\/\/doi.org\/10.1016\/j.molstruc.2021.130652","journal-title":"J Mol Struct"},{"key":"10862_CR78","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.molstruc.2010.05.041","volume":"977","author":"SA Sadeek","year":"2010","unstructured":"Sadeek SA, El-Shwiniy WH (2010) Metal complexes of the fourth generation quinolone antimicrobial drug gatifloxacin: synthesis, structure and biological evaluation. J Mol Struct 977:243\u2013253. https:\/\/doi.org\/10.1016\/j.molstruc.2010.05.041","journal-title":"J Mol Struct"},{"key":"10862_CR79","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.ejmech.2017.07.004","volume":"138","author":"DH Soliman","year":"2017","unstructured":"Soliman DH, Abdelrahman MA, Gomaa MS, Elasser MM, AbdelAziz MM, Salama I (2017) Design, synthesis and 2D QSAR study of novel pyridine and quinolone hydrazone derivatives as potential antimicrobial and antitubercular agents. Eur J Med Chem 138:698\u2013714. https:\/\/doi.org\/10.1016\/j.ejmech.2017.07.004","journal-title":"Eur J Med Chem"},{"key":"10862_CR80","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1007\/s00044-011-9728-8","volume":"21","author":"NB Patel","year":"2012","unstructured":"Patel NB, Pathak KK (2012) Pyridoquinolones containing azetidinones: synthesis and their biological evaluation. Med Chem Res 21:2044\u20132055. https:\/\/doi.org\/10.1007\/s00044-011-9728-8","journal-title":"Med Chem Res"},{"key":"10862_CR81","doi-asserted-by":"publisher","first-page":"3267","DOI":"10.1016\/j.bmcl.2013.03.118","volume":"23","author":"SF Cui","year":"2013","unstructured":"Cui SF, Ren Y, Zhang SL, Peng XM, Damu GL, Geng RX, Zhou CH (2013) Synthesis and biological evaluation of a class of quinolone triazoles as potential antimicrobial agents and their interactions with calf thymus DNA. Bioorg Med Chem Lett 23:3267\u20133272. https:\/\/doi.org\/10.1016\/j.bmcl.2013.03.118","journal-title":"Bioorg Med Chem Lett"},{"key":"10862_CR82","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.antiviral.2017.12.019","volume":"150","author":"P Luthra","year":"2018","unstructured":"Luthra P, Liang J, Pietzsch CA, Khadka S, Edwards MR, Wei S, De S, Posner B, Bukreyev A, Ready JM, Basler CF (2018) A high throughput screen identifies benzoquinoline compounds as inhibitors of Ebola virus replication. Antivi res 150:193\u2013201. https:\/\/doi.org\/10.1016\/j.antiviral.2017.12.019","journal-title":"Antivi res"},{"key":"10862_CR83","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s40261-018-0656-y","volume":"38","author":"D Plantone","year":"2018","unstructured":"Plantone D, Koudriavtseva T (2018) Current and future use of chloroquine and hydroxychloroquine in infectious, immune, neoplastic, and neurological diseases: a mini-review. Clin Drug Investig 38:653\u2013671. https:\/\/doi.org\/10.1007\/s40261-018-0656-y","journal-title":"Clin Drug Investig"},{"key":"10862_CR84","unstructured":"World Health Organization (2022) Summary of the global HIV epidemic https:\/\/www.who.int\/health-topics\/hiv-aids#tab=tab_1."},{"key":"10862_CR85","doi-asserted-by":"publisher","first-page":"1900045","DOI":"10.1002\/ardp.201900045","volume":"352","author":"R Wang","year":"2019","unstructured":"Wang R, Xu K, Shi W (2019) Quinolone derivatives: potential anti-HIV agent\u2014development and application. Arch Pharm 352:1900045. https:\/\/doi.org\/10.1002\/ardp.201900045","journal-title":"Arch Pharm"},{"key":"10862_CR86","doi-asserted-by":"publisher","first-page":"671","DOI":"10.3109\/14756366.2012.668540","volume":"28","author":"QQ He","year":"2013","unstructured":"He QQ, Zhang X, Yang LM, Zheng YT, Chen F (2013) Synthesis and biological evaluation of 5-fluoroquinolone-3-carboxylic acids as potential HIV-1 integrase inhibitors. J Enzyme Inhib Med Chem 28:671\u2013676. https:\/\/doi.org\/10.3109\/14756366.2012.668540","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10862_CR87","doi-asserted-by":"publisher","first-page":"6615","DOI":"10.3109\/14756366.2012.668540","volume":"58","author":"B Mercorelli","year":"2014","unstructured":"Mercorelli B, Luganini A, Muratore G, Massari S, Terlizzi ME, Tabarrini O, Gribaudo G, Loregian PG, A (2014) The 6-Aminoquinolone WC5 inhibits different functions of the immediate-early 2 (IE2) protein of human cytomegalovirus that are essential for viral replication. Antimicrob Agents Chemother 58:6615\u20136626. https:\/\/doi.org\/10.3109\/14756366.2012.668540","journal-title":"Antimicrob Agents Chemother"},{"key":"10862_CR88","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1080\/10426507.2017.1394302","volume":"193","author":"N Parizadeh","year":"2017","unstructured":"Parizadeh N, Alipour E, Soleymani S, Zabihollahi R, Aghasadeghi MR, Hajimahdi Z, Zarghi A (2017) Synthesis of novel 3-(5-(Alkyl\/arylthio)-1,3,4-oxadiazol-2-yl)-8-phenylquinolin-4 (1 H)-one derivatives as anti-HIV agents. Phosphorus Sulfur Relat Elem 193:225\u2013231. https:\/\/doi.org\/10.1080\/10426507.2017.1394302","journal-title":"Phosphorus Sulfur Relat Elem"},{"key":"10862_CR89","doi-asserted-by":"publisher","first-page":"4658","DOI":"10.1016\/j.bmc.2014.07.018","volume":"22","author":"L Sancineto","year":"2014","unstructured":"Sancineto L, Iraci N, Barreca ML, Massari S, Manfroni G, Corazza G, Cecchetti V, Marcello A, Daelemans D, Pannecouque C, Tabarrini O (2014) Exploiting the anti-HIV 6-desfluoroquinolones to design multiple ligands. Bioorg Med Chem 22:4658\u20134666. https:\/\/doi.org\/10.1016\/j.bmc.2014.07.018","journal-title":"Bioorg Med Chem"},{"key":"10862_CR90","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1007\/s00044-020-02546-z","volume":"29","author":"AM Jassem","year":"2020","unstructured":"Jassem AM, Dhumad AM, Almashal FA, Alshawi JM (2020) Microwave-assisted synthesis, molecular docking and anti-HIV activities of some drug-like quinolone derivatives. Med Chem Res 29:1067\u20131076. https:\/\/doi.org\/10.1007\/s00044-020-02546-z","journal-title":"Med Chem Res"},{"key":"10862_CR91","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.4028\/www.scientific.net\/amr.634-638.1116","volume":"634\u2013638","author":"XM Xu","year":"2013","unstructured":"Xu XM, Luo ZG, He K, Zhang MY (2013) Synthesis and biological evaluation of quinolone acid derivatives having polyhydroxylated aromatics as HIV-1 integrase inhibitions. AMR 634\u2013638:1116\u20131119. https:\/\/doi.org\/10.4028\/www.scientific.net\/amr.634-638.1116","journal-title":"AMR"},{"key":"10862_CR92","unstructured":"WHO Guidelines for malaria, (2023)."},{"key":"10862_CR93","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.exppara.2007.10.016","volume":"118","author":"RW Winter","year":"2008","unstructured":"Winter RW, Kelly JX, Smilkstein MJ, Dodean R, Hinrichs D, Riscoe MK (2008) Antimalarial quinolones: synthesis, potency, and mechanistic studies. Exp Parasitol 118:487\u2013497. https:\/\/doi.org\/10.1016\/j.exppara.2007.10.016","journal-title":"Exp Parasitol"},{"key":"10862_CR94","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejmech.2018.01.039","volume":"146","author":"YL Fan","year":"2018","unstructured":"Fan YL, Cheng XW, Wu JB, Liu M, Zhang FZ, Xu Z, Feng LS (2018) Antiplasmodial and antimalarial activities of quinolone derivatives: an overview. Eur J Med Chem 146:1\u201314. https:\/\/doi.org\/10.1016\/j.ejmech.2018.01.039","journal-title":"Eur J Med Chem"},{"key":"10862_CR95","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.ejmech.2012.02.006","volume":"51","author":"SK Dixit","year":"2012","unstructured":"Dixit SK, Mishra N, Sharma M, Singh S, Agarwal A, Awasthi SK, Bhasin VK (2012) Synthesis and in vitro antiplasmodial activities of fluoroquinolone analogs. Eur J Med Chem 51:52\u201359. https:\/\/doi.org\/10.1016\/j.ejmech.2012.02.006","journal-title":"Eur J Med Chem"},{"key":"10862_CR96","doi-asserted-by":"publisher","first-page":"2756","DOI":"10.1016\/j.bmc.2010.02.013","volume":"18","author":"Y Zhang","year":"2010","unstructured":"Zhang Y, Guiguemde WA, Sigal M, Zhu F, Connelly MC, Nwaka S, Guy RK (2010) Synthesis and structure\u2013activity relationships of antimalarial 4-oxo-3-carboxyl quinolones. Bioorg Med Chem 18:2756\u20132766. https:\/\/doi.org\/10.1016\/j.bmc.2010.02.013","journal-title":"Bioorg Med Chem"},{"key":"10862_CR97","doi-asserted-by":"publisher","first-page":"3818","DOI":"10.1021\/jm500147k","volume":"57","author":"A Nilsen","year":"2014","unstructured":"Nilsen A, Miley GP, Forquer IP, Mather MW, Katneni K, Li Y, Pou S et al (2014) Discovery, synthesis, and optimization of antimalarial 4 (1 H)-quinolone-3-diarylethers. J Med Chem 57:3818\u20133834. https:\/\/doi.org\/10.1021\/jm500147k","journal-title":"J Med Chem"},{"key":"10862_CR98","doi-asserted-by":"publisher","first-page":"14204","DOI":"10.3390\/molecules190914204","volume":"19","author":"A Wube","year":"2014","unstructured":"Wube A, H\u00fcfner A, Seebacher W, Kaiser M, Brun R, Bauer R, Bucar F (2014) 1,2-Substituted 4-(1H)-quinolones: synthesis, antimalarial and antitrypanosomal activities in Vitro. Molecules 19:14204\u201314220. https:\/\/doi.org\/10.3390\/molecules190914204","journal-title":"Molecules"},{"key":"10862_CR99","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmcr.2021.100012","volume":"3","author":"JO de Souza","year":"2021","unstructured":"de Souza JO, Almeida SM, Souza GE, Zanini CL, da Silva EM, Calit J et al (2021) Parasitological profiling shows 4 (1H)-quinolone derivatives as new lead candidates for malaria. Euro J Med Chem Reports 3:100012. https:\/\/doi.org\/10.1016\/j.ejmcr.2021.100012","journal-title":"Euro J Med Chem Reports"},{"key":"10862_CR100","doi-asserted-by":"publisher","first-page":"6943","DOI":"10.1021\/acs.jmedchem.6b00759","volume":"59","author":"JR Maignan","year":"2016","unstructured":"Maignan JR, Lichorowic CL, Giarrusso J, Blake LD, Casandra D, Mutka TS (2016) ICI 56,780 Optimization: structure\u2013activity relationship studies of 7-(2-Phenoxyethoxy)-4 (1 H)-quinolones with antimalarial activity. J Med Chem 59:6943\u20136960. https:\/\/doi.org\/10.1021\/acs.jmedchem.6b00759","journal-title":"J Med Chem"},{"key":"10862_CR101","unstructured":"WHO Global tuberculosis report (2022). https:\/\/www.who.int\/teams\/global-tuberculosis-programme\/tb-reports."},{"key":"10862_CR102","unstructured":"Mohajan H (2014) Tuberculosis is a fatal disease among some developing countries of the world. Tuberculosis is a Fatal Disease among Some Developing Countries of the World 3:18\u201321. https:\/\/mpra.ub.uni-muenchen.de\/82851\/."},{"key":"10862_CR103","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.ejmech.2018.10.031","volume":"161","author":"A Carta","year":"2019","unstructured":"Carta A, Bua A, Corona P, Piras S, Briguglio I, Molicotti P, Zanetti S, Laurini E, Aulic S, Fermeglia M, Pricl S (2019) Design, synthesis and antitubercular activity of 4-alkoxy-triazoloquinolones able to inhibit the M. tuberculosis DNA gyrase. Eur J Med Chem 161:399\u2013415. https:\/\/doi.org\/10.1016\/j.ejmech.2018.10.031","journal-title":"Eur J Med Chem"},{"key":"10862_CR104","doi-asserted-by":"publisher","first-page":"268","DOI":"10.3390\/molecules21040268","volume":"21","author":"A Naeem","year":"2016","unstructured":"Naeem A, Badshah SL, Muska M, Ahmad N, Khan K (2016) The current case of quinolones: synthetic approaches and antibacterial activity. Molecules 21:268. https:\/\/doi.org\/10.3390\/molecules21040268","journal-title":"Molecules"},{"key":"10862_CR105","doi-asserted-by":"publisher","first-page":"455","DOI":"10.2174\/092986706775527965","volume":"13","author":"MV De Souza","year":"2006","unstructured":"De Souza MV, Vasconcelos TR, Almeida MVD, Cardoso SH (2006) Fluoroquinolones: an important class of antibiotics against tuberculosis. Curr Med Chem 13:455\u2013463. https:\/\/doi.org\/10.2174\/092986706775527965","journal-title":"Curr Med Chem"},{"key":"10862_CR106","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1042\/BJ20130430","volume":"455","author":"A Bouige","year":"2013","unstructured":"Bouige A, Darmon A, Piton J, Roue M, Petrella S, Capton E, Forterre P, Aubry A, Mayer C (2013) Mycobacterium tuberculosis DNA gyrase possesses two functional GyrA-boxes. Biochem J 455:285\u2013294. https:\/\/doi.org\/10.1042\/BJ20130430","journal-title":"Biochem J"},{"key":"10862_CR107","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a025320","volume":"6","author":"DC Hooper","year":"2016","unstructured":"Hooper DC, Jacoby GA (2016) Topoisomerase inhibitors: fluoroquinolone mechanisms of action and resistance. Cold Spring Harb Perspect Med 6:a025320. https:\/\/doi.org\/10.1101\/cshperspect.a025320","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10862_CR108","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.ejmech.2018.04.059","volume":"152","author":"SL Badshah","year":"2018","unstructured":"Badshah SL, Ullah A (2018) New developments in non-quinolone-based antibiotics for the inhibiton of bacterial gyrase and topoisomerase IV. Eur J Med Chem 152:393\u2013400. https:\/\/doi.org\/10.1016\/j.ejmech.2018.04.059","journal-title":"Eur J Med Chem"},{"key":"10862_CR109","doi-asserted-by":"publisher","first-page":"24095","DOI":"10.1039\/D0RA09250A","volume":"11","author":"KL Liu","year":"2021","unstructured":"Liu KL, Teng F, Xiong L, Li X, Gao C, Yu LT (2021) Discovery of quinolone derivatives as antimycobacterial agents. RSC Adv 11:24095\u201324115. https:\/\/doi.org\/10.1039\/D0RA09250A","journal-title":"RSC Adv"},{"key":"10862_CR110","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2023.115539","volume":"258","author":"PS Dube","year":"2023","unstructured":"Dube PS, Legoabe LJ, Jordaan A, Sigauke L, Warner DF, Beteck RM (2023) Quinolone analogues of benzothiazinone: synthesis, antitubercular structure-activity relationship and ADME profiling. Eur J Med Chem 258:115539. https:\/\/doi.org\/10.1016\/j.ejmech.2023.115539","journal-title":"Eur J Med Chem"},{"key":"10862_CR111","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1007\/s00044-022-02891-1","volume":"31","author":"CA Ribeiro","year":"2022","unstructured":"Ribeiro CA, dos Reis DB, Reis IF, de Carvalho AN, Louren\u00e7o MC, de Souza MV, Pinheiro AC, Saraiva MF (2022) Synthesis and antimycobacterial evaluation of fluoroquinolones derivatives coupled with isoprenyl moiety at the C-7 position. Med Chem Res 31:949\u2013959. https:\/\/doi.org\/10.1007\/s00044-022-02891-1","journal-title":"Med Chem Res"},{"key":"10862_CR112","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1007\/s00044-019-02372-y","volume":"28","author":"HA Aziz","year":"2019","unstructured":"Aziz HA, Moustafa GA, Abbas SH, Hauk G, Siva Krishna V, Sriram D, Berger JM, Abuo-Rahma GEDA (2019) New fluoroquinolones\/nitric oxide donor hybrids: design, synthesis and antitubercular activity. Med Chem Res 28:1272\u20131283. https:\/\/doi.org\/10.1007\/s00044-019-02372-y","journal-title":"Med Chem Res"},{"key":"10862_CR113","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2019.102965","volume":"88","author":"A Ture","year":"2019","unstructured":"Ture A, Kulabas N, Dingis SI, Birgul K, Bozdeveci A, Karaoglu SA, Krishna VS, Sriram D, Kucukguzel I (2019) Design, synthesis and molecular modeling studies on novel moxifloxacin derivatives as potential antibacterial and antituberculosis agents. Bioorg Chem 88:102965. https:\/\/doi.org\/10.1016\/j.bioorg.2019.102965","journal-title":"Bioorg Chem"},{"issue":"7","key":"10862_CR114","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.3390\/molecules22071171","volume":"22","author":"Z Xu","year":"2017","unstructured":"Xu Z, Zhang S, Feng LS, Li XN, Huang GC, Chai Y, Lv ZS, Guo HY, Liu ML (2017) Synthesis and in vitro antimycobacterial and antibacterial activity of 8-OMe ciprofloxacin-hydrozone\/azole hybrids. Molecules 22(7):1171. https:\/\/doi.org\/10.3390\/molecules22071171","journal-title":"Molecules"},{"issue":"10110","key":"10862_CR115","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1016\/S0140-6736(17)31510-6","volume":"390","author":"P Buscher","year":"2017","unstructured":"Buscher P, Cecchi G, Jamonneau V, Priotto G (2017) Human african trypanosomiasis. The Lancet 390(10110):2397\u20132409. https:\/\/doi.org\/10.1016\/S0140-6736(17)31510-6","journal-title":"The Lancet"},{"key":"10862_CR116","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.pt.2018.08.006","volume":"34","author":"CH Baker","year":"2018","unstructured":"Baker CH, Welburn SC (2018) The long wait for a new drug for human African trypanosomiasis. Trends Parasitol 34:818\u2013827. https:\/\/doi.org\/10.1016\/j.pt.2018.08.006","journal-title":"Trends Parasitol"},{"key":"10862_CR117","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2021.113913","volume":"227","author":"KT Angula","year":"2022","unstructured":"Angula KT, Legoabe LJ, Swart T, Hoppe HC, Beteck RM (2022) Synthesis and in vitro antitrypanosomal evaluation of novel 6-heteroarylidene-substituted quinolone derivatives. Eur J Med Chem 227:113913. https:\/\/doi.org\/10.1016\/j.ejmech.2021.113913","journal-title":"Eur J Med Chem"},{"key":"10862_CR118","doi-asserted-by":"publisher","first-page":"188","DOI":"10.17159\/0379-4350\/2018\/v71a25","volume":"71","author":"RM Beteck","year":"2018","unstructured":"Beteck RM, Isaacs M, Hoppe HC, Khanye SD (2018) Synthesis, in vitro cytotoxicity and trypanocidal evaluation of novel 1, 3, 6-substituted non-fluoroquinolones. S Afr J Chem 71:188\u2013195","journal-title":"S Afr J Chem"},{"key":"10862_CR119","doi-asserted-by":"publisher","first-page":"5168","DOI":"10.1016\/j.bmc.2015.03.029","volume":"23","author":"S Pomel","year":"2015","unstructured":"Pomel S, Dubar F, Forge D, Loiseau PM, Biot C (2015) New heterocyclic compounds: synthesis and antitrypanosomal properties. Bioorg Med Chem 23:5168\u20135174. https:\/\/doi.org\/10.1016\/j.bmc.2015.03.029","journal-title":"Bioorg Med Chem"},{"key":"10862_CR120","doi-asserted-by":"publisher","first-page":"4442","DOI":"10.1128\/aac.01757-15","volume":"60","author":"G Hiltensperger","year":"2016","unstructured":"Hiltensperger G, Hecht N, Kaiser M, Rybak JC, Hoerst A, Dannenbauer N, Muller-Buschbaum K, Bruhn H, Esch H, Lehmann L, Meinel L, Holzgrabe U (2016) Quinolone amides as antitrypanosomal lead compounds with in vivo activity. Antimicrob Agents Ch 60:4442\u20134452. https:\/\/doi.org\/10.1128\/aac.01757-15","journal-title":"Antimicrob Agents Ch"},{"key":"10862_CR121","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.bmcl.2008.11.078","volume":"19","author":"X Ma","year":"2009","unstructured":"Ma X, Zhou W, Brun R (2009) Synthesis, in vitro antitrypanosomal and antibacterial activity of phenoxy, phenylthio or benzyloxy substituted quinolones. Bioorg Med Chem Lett 19:986\u2013989. https:\/\/doi.org\/10.1016\/j.bmcl.2008.11.078","journal-title":"Bioorg Med Chem Lett"},{"key":"10862_CR122","unstructured":"Roy S, Chandrasekaran SK, Imamori K, Asaoka T, Shibata A, Takahashi M, Bowman LM (2004) Patent US6699492B2."},{"key":"10862_CR123","unstructured":"DE Souza NJ, Patel MV, Deshpande PK, Agarwal SK, Sreenivas K, Nair SC, Chugh Y Shukla, MC (2008) Patent US7393957B2."},{"key":"10862_CR124","unstructured":"Ledoussal B, Hu XE, Almstead J, Gray JL (2001) Patent WO2002048138A1."},{"key":"10862_CR125","unstructured":"Ledoussal B, Almstead JK, Gray JL (2011) Patent US7868021B2."},{"key":"10862_CR126","unstructured":"Bradbury BJ, Deshpande M, Pucci MJ, Wang Q, Wiles JA, Song Y, Hashimoto A, Lucien E (2013) Patent EP1664062B1."},{"key":"10862_CR127","unstructured":"Manetsch R, Kyle DE, Neelarapu R, Maignan JR, Lichorowic CL, LaCrue AN (2018) Patent US10000452B1."},{"key":"10862_CR128","unstructured":"Xu B, Zhu Q, Cho H, Fathi R, Yang Z, Sandrasagra A, Liu Y (2006) Patent US20060223783A1."},{"key":"10862_CR129","unstructured":"Daube G, Edingloh M, Limet A, Pirro F, Stephan B (2012). Patent AU2011200356B2."},{"key":"10862_CR130","unstructured":"Grant Iii, RB Macielag, MJ Paget, SD, Weidner-Wells MA, Xu X, Xu X (2015). Patent DK1861401T3."},{"key":"10862_CR131","unstructured":"Kapsner T, Dalhoff A (2013) Patent ES2838724T3."},{"key":"10862_CR132","unstructured":"Oethinger M, Levy B (2011) Patent US8012711B2."}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-024-10862-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-024-10862-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-024-10862-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T16:41:40Z","timestamp":1738341700000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-024-10862-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,29]]},"references-count":132,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["10862"],"URL":"https:\/\/doi.org\/10.1007\/s11030-024-10862-4","relation":{},"ISSN":["1381-1991","1573-501X"],"issn-type":[{"value":"1381-1991","type":"print"},{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,29]]},"assertion":[{"value":"16 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}